LOGEN Amends Merger Registration Statement with MODA INNOCHEM, Massive Dilution and Financial Strain
LOGEN has filed an amendment to its securities registration statement for the absorption merger with MODA INNOCHEM, finalizing a merger ratio of 1:0.9755740 and issuing 76,394,770 new shares. This represents approximately 136% dilution of existing shares, severely impacting current shareholder value.
On a consolidated basis for Q1 2026, the acquiring company LOGEN reported operating profit of KRW 3.0 billion and net income of KRW 0.1 billion, while the target MODA INNOCHEM recorded a net loss of KRW 4.9 billion. Pro forma combined financials show a net loss of KRW 3.1 billion, indicating poor profitability improvement.
Post-merger, the controlling shareholder Daemyung Chemical's stake will rise from 48.78% to 64.82%, strengthening control. The combined debt ratio is around 142% and interest coverage ratio of 0.8 times implies financial costs exceed operating profit.
The target company's Q1 2026 sales decreased 8.4% year-on-year and operating profit plunged 61.9%, reflecting persistent deterioration. Additional concerns include asset quality issues such as goodwill impairment of KRW 2.1 billion and cumulative inventory valuation loss of KRW 12.6 billion.
The merger may be terminated if the aggregate exercise of appraisal rights exceeds KRW 10 billion, and there is potential for minority shareholder litigation. Neither company paid dividends in 2025, indicating no shareholder returns.
[AI Summary]LOGEN's merger with MODA INNOCHEM leads to severe dilution of 136% for existing shareholders, and both companies showed extremely low profitability in Q1 2026 with a combined net loss expected post-merger, making near-term financial improvement unlikely. High debt ratio and low interest coverage ratio undermine financial stability, while the controlling shareholder's increased stake may weaken minority shareholder rights.
KOSDAQ Filing Information
[Correction of Description] Securities Registration Statement (Merger)